Zhou P - Search Results

1

Powerful protection against renal ischemia reperfusion injury by T cell-specific NF-κB inhibition.

Xue C, Liu Y, Li C, Li Y, Yang T, Xie L, Zhou P. Xue C, et al. Among authors: zhou p. Transplantation. 2014 Feb 27;97(4):391-6. doi: 10.1097/01.TP.0000438622.89310.95. Transplantation. 2014. PMID: 24398854

2

Porcine hepatocyte isolation and reversible immortalization mediated by retroviral transfer and site-specific recombination.

Meng FY, Chen ZS, Han M, Hu XP, He XX, Liu Y, He WT, Huang W, Guo H, Zhou P. Meng FY, et al. Among authors: zhou p. World J Gastroenterol. 2010 Apr 7;16(13):1660-4. doi: 10.3748/wjg.v16.i13.1660. World J Gastroenterol. 2010. PMID: 20355246 Free PMC article.

3

NF-κB downregulates Cbl-b through binding and suppressing Cbl-b promoter in T cell activation.

Liu Y, Li Y, Zhang L, Li M, Li C, Xue C, Huang X, Zhou P. Liu Y, et al. Among authors: zhou p. J Immunol. 2015 Apr 15;194(8):3778-83. doi: 10.4049/jimmunol.1402104. Epub 2015 Mar 11. J Immunol. 2015. PMID: 25762784

4

Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.

Xie L, Jiang FC, Zhang LM, He WT, Liu JH, Li MQ, Zhang X, Xing S, Guo H, Zhou P. Xie L, et al. Among authors: zhou p. J Natl Cancer Inst. 2015 Dec 28;108(4):djv364. doi: 10.1093/jnci/djv364. Print 2016 Apr. J Natl Cancer Inst. 2015. PMID: 26712311

5

Short-term MyD88 inhibition ameliorates cardiac graft rejection and promotes donor-specific hyporesponsiveness of skin grafts in mice.

He WT, Zhang LM, Li C, Li SY, Ding ZC, Fang ZM, Meng FY, Chen ZK, Zhou P. He WT, et al. Among authors: zhou p. Transpl Int. 2016 Aug;29(8):941-52. doi: 10.1111/tri.12789. Epub 2016 Jun 14. Transpl Int. 2016. PMID: 27125343 Free article.

6

Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro.

Zhang LM, Liu JH, Xue CB, Li MQ, Xing S, Zhang X, He WT, Jiang FC, Lu X, Zhou P. Zhang LM, et al. Among authors: zhou p. Sci Rep. 2016 Jun 1;6:26954. doi: 10.1038/srep26954. Sci Rep. 2016. PMID: 27246399 Free PMC article.

7

Beyond knockout: A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice.

Zhang X, Xing S, Li M, Zhang L, Xie L, He W, Liu J, Chang S, Jiang F, Zhou P. Zhang X, et al. Among authors: zhou p. Metabolism. 2016 Sep;65(9):1267-77. doi: 10.1016/j.metabol.2016.05.005. Epub 2016 May 14. Metabolism. 2016. PMID: 27506734

8

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Li C, Zhang LM, Zhang X, Huang X, Liu Y, Li MQ, Xing S, Yang T, Xie L, Jiang FC, Jiang HY, He WT, Zhou P. Li C, et al. Among authors: zhou p. Transplantation. 2017 Feb;101(2):284-293. doi: 10.1097/TP.0000000000001471. Transplantation. 2017. PMID: 27607533

9

A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-β1-Induced EMT in Vivo and in Vitro.

Liu JH, He L, Zou ZM, Ding ZC, Zhang X, Wang H, Zhou P, Xie L, Xing S, Yi CZ. Liu JH, et al. Among authors: zhou p. Kidney Blood Press Res. 2018;43(5):1677-1687. doi: 10.1159/000494745. Epub 2018 Oct 31. Kidney Blood Press Res. 2018. PMID: 30380557 Free article.

10

Modulating the conformation of the TIR domain by a neoteric MyD88 inhibitor leads to the separation of GVHD from GVT.

Xing S, Zhang X, Huang X, Xie L, Jiang F, Zhou P. Xing S, et al. Among authors: zhou p. Leuk Lymphoma. 2019 Jun;60(6):1528-1539. doi: 10.1080/10428194.2018.1537487. Epub 2018 Dec 3. Leuk Lymphoma. 2019. PMID: 30501537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,624 results

Search Page

Filters